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Nutrition in neurological disability in paediatrics: 
cerebral palsy
The case study has been adapted from the original case discussion at the South African Society for Parenteral and Enteral Nutrition (SASPEN) 
2011 Congress held at Diep-in-die-Berg, Pretoria. A summarised discussion of the case follows.
Introduction
The learning objectives of the case study were:
•	 To discuss the growth monitoring of children with cerebral palsy 
(CP). Which growth charts should, or could, be used?
•	 To discuss the nutritional recommendations of infants and 
children with CP.
•	 To discuss the possible drug-nutrient interactions and the 
nutrition-related side-effects of anticonvulsants.
•	 To discuss ethical considerations concerning the placement of 
gastrostomy tubes in infants and children with CP.
Case study 
The patient was a seven-month-old male, admitted to a tertiary 
hospital in South Africa, while his parents were visiting from a 
neighboring developing country with an immature healthcare 
system. 
He was admitted with the following diagnoses:
•	 Bronchopneumonia
•	 Cerebral palsy (CP) with spastic diplegia: CP can be defined as a 
disorder of aberrant control of movement and posture, appearing 
early in life, secondary to a central nervous system lesion or 
dysfunction that is not the result of recognised progressive or 
degenerative brain disease. The diagnosis of CP always involves 
a motor deficit.1 “Spastic” describes the muscle tone that is 
increased in spastic diplegia usually, as opposed to hypotonia. 
“Diplegia” is motor impairment of both legs primarily, with limited 
involvement of the arms.2,3
•	 Epilepsy with breakthrough seizures
•	 Marasmus.
Upon admission, he was referred to the attending dietitian for 
nutrition care.
Background 
The patient was born term, but due to a delayed labour process, 
suffered neurological damage during the birth. This caused seizures 
after the birth, and CP with spastic diplegia. He had a history of 
several previous admissions to hospital in his home country, as well 
as seizures and pneumonia. 
Although his mother was retroviral disease (RVD) positive, the 
infant tested polymerase chain reaction (PCR) for RVD negative at 
six months of age. The father was also RVD positive, but neither he 
nor his wife were receiving antiretroviral (ARV) therapy. Both parents 
were unemployed.
Table I: Patient’s anthropometric parameters
Admission
(age 7 months) Day 1 Day 7 Day 13 Day 20
Weight 3 250 g 3 800 g 4 300 g 5 130 g 4 140 g
Length 53cm
Causes of the apparent discrepancy in the patient’s 
weight between days 13 and 20
The weight discrepancy between day 13 and 20 could not be 
explained as easily as that between days 1 and 7. It is highly likely 
that there was an element of dehydration upon admission, and that 
this was subsequently corrected. There could be many reasons 
for the discrepancy between days 13 and 20, including inaccurate 
weighing methods, e.g. with or without clothes and splints, different 
scales, or fluid overload or retention. Unfortunately, no albumin or 
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C-reactive protein (CRP) levels were available to correctly determine 
the cause. However, a review of the progress notes and nutrition 
prescription showed high fluid allowances around day 7 (177 ml/kg/
day) at times, in order to meet the nutritional requirements. On day 
13, the fluid intake was reduced to 129 ml/kg/day, due to feeding 
problems. However, this could be a skewed view of ml fluid/kg/day, 
due to the apparent incorrect weight on day 13. This confirms the 
importance of correct weighing, in order to be able to calculate the 
nutrition requirements correctly.
Growth charts to be used for growth monitoring in 
this population
Growth monitoring of the CP population remains difficult and 
controversial, and different growth references exist. Evidence 
suggests that this population does not exhibit the same growth 
pattern as the general population, e.g. weight-for-age percentiles of 
children with CP are lower than those in the general population.4 This 
is especially true in children with more severe motor dysfunction. Poor 
growth, loosely defined, is associated with increased hospitalisation 
and school absences. Growth charts for children with quadriplegic 
CP were developed by Krick et al5 at the Krieger Kennedy Institute, 
and have been widely used, as there were no others available. 
However, the sample size was small, and was limited to a specific 
group of CP patients.
Evidence-based thresholds for low weight, and estimates of 
associated increases in mortality risk, have been illustrated using 
new clinical growth charts for children with CP, stratified according 
to gender and gross-motor function classification system levels. 
These were developed by Day et al,4 based on more than 141 000 
measurements of almost 25 000 patients receiving services from 
the California Department of Developmental Services. However, 
these could not be used in the case of the patient under discussion, 
as they are only available for patients who are two years and older. 
Wittenbrook6 recommends that the Centres for Disease Control and 
Prevention growth charts are used to monitor children with CP, even 
when measurements are consistently below the fifth percentile. The 
goal is to have appropriate growth velocity, and for the child to follow 
his or her growth curve. Disease-specific growth charts are available 
to assess the “typical” growth related to the various syndromes, and 
could be used for our patient, but small sample sizes, age ranges, 
and lack of availability in acute care settings, limit their use. Close 
monitoring still remains the best practice as there are too few 
sufficiently powered studies to provide evidence-based references 
for CP children in the 0-2 years’ age group.6,7 It is important to 
determine if a particular child maintains his or her individual growth 
velocity, irrespective of which growth charts are used.
Table II reflects blood counts and available biochemistry results for 
certain days of the patient’s admission to hospital.
Interpretation of the urea and creatinine results 
Creatinine is a product of muscle creatinine-phosphate metabolism, 
and its level parallels muscle mass. Urea is produced in the liver 
from protein degradation.8 In this case, the patient was diagnosed 
with marasmus which is characterised by muscle wasting, so the 
low urea and creatinine levels were not unexpected. 
Clinical signs
Clinical signs included:
•	 Irritability and crying, but the patient was consolable
•	 Coughing
•	 Vomiting (one episode)
•	 Increased tone globally
•	 Increased reflexes globally
•	 Cervical lymphadenopathy.
Clinical signs that should be of concern to the 
dietitian, and why
Coughing and vomiting are taken to be evidence of swallowing 
dysfunction. This was confirmed by a video fluoroscopy. The vomiting 
prevented optimal intake by mouth. 
Increased tone and reflexes: Increased energy requirements, as 
compared to children with severe motor dysfunction.7 
Diet history
The baby was fed with a breast milk substitute. Initially, he received 
two bottles of 200ml Nan 1® per day (eight scoops of powder). 
Introduction to solids was started at five months of age. When at 
home, he consumed Nestum® cereal and Purity® orally. His mother 
reported oral feeding difficulties.
Factors that influence the nutrition requirements of 
infants with cerebral palsy
Mobility and muscle tone
The level of gross motor function impairment will determine physical 
activity and muscle tone, and will influence energy requirements. 
For example, children with athetoid CP or hypertonia may have 
increased requirements, whereas children with hypotonia will have 
decreased requirements.7
Table II: Blood counts and biochemistry results for selected days during 
admission to hospital
 Day 1 Day 4 Day 15 Day 25
White cell count 31.2 high 21.47 high 4.22 7.73
Haemoglobin 11.5 10.8 9.9 low 10.9
Hct 0.33 0.3 32 0.30 0.32
Mean corpuscular volume 84.3 85.1 88.3 87.0
Sodium 140 139 139 138
Potassium 4.8 4.2 4.5 4.1
Chloride 106 100 99 100
CO2 20 low 21 low 27 23 low
Urea 2.2 low 2.5 low 2.7 low 2.6 low
Creatinine 35 low 32 low 28 low < 20 low
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Dysphagia and feeding ability
It is important to determine whether optimal intake by mouth is 
possible.7
Medications and their side-effects
Medications to reduce hypertonia often reduce energy expenditure. 
Some antipsychotics lead to weight gain, due to appetite stimulation.6
Bowel actions
Dysmotility, hypotonia, medications, and non-ambulation contribute 
to constipation.6 
Pulmonary status
Progressive fatigue towards the end of a meal may be an indication 
of silent aspiration and desaturation.9
The protein and energy recommendations for infants 
with cerebral palsy
Energy
Disability-specific standards for estimating energy needs in children 
with CP are available. However, they are often of limited use due 
to small sample size, limited studied age ranges, and the necessity 
for accurate stature measurement. Typical prediction equations 
can overestimate requirements by as much as 20%, leading to 
an overweight individual. No two CP individuals are the same, and 
energy needs must be adjusted regularly, according to the current 
medical status. It is not uncommon to see a hypotonic, hypometabolic 
individual with CP maintain his or her weight with a very low energy 
intake. This poses another challenge to the dietitian as micronutrient 
requirements are then often not met. Supplementation with age-
appropriate vitamin and mineral supplements is then indicated 
to meet at least the daily recommended intake (DRI). Individual 
requirements may be different, based on the current medical 
condition.6,7 
Protein
The DRI is used to estimate protein requirements based on actual 
weight.6,7 Therefore, it is evident that once again, close and regular 
monitoring remains the best practice to assure optimal growth and 
development of the CP patient.
Medication
Medication includes Amikacin®, Panado®, Epilim®, Rivotril®, and 
Phenytoin.®
Medications that impact on enteral nutrition support 
and medical treatment: limiting their impact
Phenytoin
When administered concurrently with food, phenytoin absorption 
may be reduced by up to 70%, thus decreasing serum drug levels. 
There are two possible ways that the impact can be limited:
•	 Hold back feeding for two hours before and after feeds, and flush 
the feeding tube with water after each dosing.
•	 If feeds cannot be held for the recommended times, the dose of 
phenytoin should be adjusted to assure the required therapeutic 
drug level.10
Micronutrients that should be of concern with the use 
of anticonvulsants
Folate and other B-vitamins
Some anticonvulsants decrease s-levels of folate, Vitamin B12, biotin 
and thiamine.11 Furthermore, frequently prescribed anticonvulsant 
medications, such as valproic acid, phenytoin and carbamazepine, 
are associated with alterations in Vitamin D and calcium metabolism, 
and should be closely monitored.7 
Table III summarises the progress notes of some members of the 
interdisciplinary healthcare team involved in the rehabilitation of the 
patient, i.e. the clinical dietitian, speech therapist and physiotherapist.
The patient continued to receive intensive rehabilitation therapy from 
the occupational, physical and speech therapists, while awaiting the 
barium swallow and a percutaneous endoscopic gastrostomy (PEG) 
placement. It was expected that the patient would be discharged 
after successful PEG placement, to return with his parents to his 
home country. 
Practical issues that might influence the long-term 
nutritional care of this patient
Practical issues that might influence the long-term nutritional care 
of this patient include:
•	 Available care in his home country, if the PEG was inserted.
•	 Household food security, in view of his parents’ lack of income.
•	 Long-term follow-up is the best practice in the absence of 
evidence-based guidelines. Regular follow-ups are recommended 
to ensure optimal growth and development.6,7,9,12 
Ethical considerations regarding placement of a 
gastrostomy tube in this patient
Many studies have shown that inserting a PEG or gastrostomy tube 
improves the nutrition status of children with CP and concurrent 
feeding difficulties, as well as improving the quality of life of the 
caregiver. 9 However, in this case, the dietitian was faced with an 
ethical dilemma of what to recommend. The availability of health 
care in the patient’s home country was of great concern, as it was not 
known if the parents would be able to receive assistance in the event 
of problems with the feeding tube, e.g. infection or dislodgement. 
It was doubtful whether there would be sustainability of nutritional 
care, due to the household’s food insecurity and the lack of family 
income. Long-term care of this patient was also problematic in 
view of the parents’ RVD status. Who would ultimately care for this 
patient? Neither of the parents were on ARV therapy that would delay 
the diseases’ progress.
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The core principles of ethics in clinical practice are beneficence 
(doing good), non-maleficence (do no harm), respect for autonomy 
(the right to self-determination) and justice (impartial, fair and just 
treatment).13 The South African dietitian registered with the Health 
Professions Council of South Africa (HPCSA) is bound to these 
principles as per the Guidelines for good practice in healthcare 
professions: general ethical guidelines for healthcare professions.14 
In this document, the healthcare professional is given guidance in 
ethical reasoning that proceeds according to four steps:
•	 Formulating the problem.
•	 Gathering information.
•	 Considering the options.
•	 Making a moral assessment. 
While following these steps, the dietitian should consult authoritative 
sources for guidance. One such source may be the Academy of 
Nutrition and Dietetics’ (formerly the American Dietetic Association) 
position on ethical and legal issues in nutrition, hydration and feeding. 
In summary, it states that healthcare team members, including 
the registered dietitian, must set treatment goals that are patient-
centered and handled individually, and must respect the values and 
decision of the patient, or in this case, that of his caregivers.15 In 
the South African context, the final decision rests with the medical 
doctor and caregiver, and the dietitian is only a consultant in the 
process, making recommendations for nutritional care, but must 
remain an advocate for the patient and his family.
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 Table III: Progress while undergoing treatment in hospital
Day Progress note
Day 3 Clinical nutrition: The feed was changed to Nan 2®, 80 ml x 
8 feeds per day (177 ml/kg/day, 120 kCal/kg, 4 g protein/
kg) and a pureé diet.
Occupational therapy: The child was unable to sit, roll, 
grasp, maintain head control, or play. It was not possible to 
arouse him. Splinting was recommended.
Physiotherapy: Physiotherapy was started with the 
facilitation of midline and supported sitting.
Day 4 Speech therapy: Gagging and coughing was observed 
during feeding. The patient could not be fed orally safely, 
and nasogastric feeding was recommended.
Day 7 Clinical nutrition: The patient’s weight was 4.3 kg. The Nan 
2® was increased to 95 ml x 8 feeds per day (177 ml/kg/
day, 120 kCal/kg, 3.9 g protein/kg). The mother reported 
one episode of vomiting after feeding. Her son passed soft 
yellow stools.
Days 8-12 Medical therapy and enteral nutrition support continued. 
Breakthrough seizures were noted. The patient was given a 
loading dose of phenytoin when the seizures occurred. This 
affected his consciousness levels.
Day 13 Clinical nutrition: The mother reported vomiting post 
feeding, and the presence of milk residue in the mouth. The 
feed volume was decreased to 85 ml x 8 feeds per day, and 
supplemented with sunflower oil and modular carbohydrate 
and protein, to meet requirements (129 ml/kg/day, 106 
kCal/kg, 3.7 g protein/kg).
Day 15 A consultant pediatrician suggested percutaneous 
endoscopic gastrostomy placement, with no post-
anaesthetic ventilation. No objective feeding assessment, 
e.g. video fluoroscopy, had been carried out. The possibility 
of percutaneous endoscopic gastrostomy was discussed 
with the mother.
Day 20 Clinical nutrition: The patient’s weight was 4.1 kg. The 
feeds were increased to Nan 2®, 95 ml x 8 feeds per day 
(supplemented, 186 ml/kg/day, 140 kCal/kg, 4 g protein/
kg).
Day 21 Speech therapy: Video fluoroscopy was carried out. Severe 
tonic bite, severe penetration and residue in the valleculae 
and pyriform sinus were noted when feeding thin or 
thickened liquids. The patient was unable to cough, or 
clear a paste consistency. The need for gastrostomy was 
confirmed. The patient was referred to paediatric surgery 
for percutanuous endoscopic gastrostomy placement. The 
paediatric surgeons required a contrast swallow study to 
rule out reflux and the necessity for a simultaneous Nissan 
fundoplication.
Day 22 - 30 On various occasions, the mother was counselled regarding 
the percutaneous endoscopic gastrostomy placement and 
feeding post placement. The patient was referred for a 
visual assessment, and was found to be blind.
